DiaMedica Therapeutics Inc. (DMAC)

DiaMedica Therapeutics Statistics

Total Valuation

DMAC has a market cap or net worth of $355.62 million. The enterprise value is $325.87 million.

Market Cap	355.62M
Enterprise Value	325.87M

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

DMAC has 51.69 million shares outstanding. The number of shares has increased by 12.37% in one year.

Current Share Class	51.69M
Shares Outstanding	51.69M
Shares Change (YoY)	+12.37%
Shares Change (QoQ)	+0.27%
Owned by Insiders (%)	47.63%
Owned by Institutions (%)	22.90%
Float	27.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	10.91
P/TBV Ratio	13.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.55, with a Debt / Equity ratio of 0.01.

Current Ratio	7.55
Quick Ratio	7.34
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -73.41% and return on invested capital (ROIC) is -48.38%.

Return on Equity (ROE)	-73.41%
Return on Assets (ROA)	-44.55%
Return on Invested Capital (ROIC)	-48.38%
Return on Capital Employed (ROCE)	-114.99%
Revenue Per Employee	n/a
Profits Per Employee	-$1.06M
Employee Count	28
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, DMAC has paid $28,000 in taxes.

Income Tax	28,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +57.08% in the last 52 weeks. The beta is 1.40, so DMAC's price volatility has been higher than the market average.

Beta (5Y)	1.40
52-Week Price Change	+57.08%
50-Day Moving Average	6.58
200-Day Moving Average	5.17
Relative Strength Index (RSI)	53.58
Average Volume (20 Days)	254,033

Short Selling Information

The latest short interest is 4.24 million, so 8.20% of the outstanding shares have been sold short.

Short Interest	4.24M
Short Previous Month	4.12M
Short % of Shares Out	8.20%
Short % of Float	15.65%
Short Ratio (days to cover)	8.27

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-31.45M
Pretax Income	-29.55M
Net Income	-29.58M
EBITDA	-31.42M
EBIT	-31.45M
Earnings Per Share (EPS)	-$0.69

Balance Sheet

The company has $30.04 million in cash and $292,000 in debt, giving a net cash position of $29.75 million or $0.58 per share.

Cash & Cash Equivalents	30.04M
Total Debt	292,000
Net Cash	29.75M
Net Cash Per Share	$0.58
Equity (Book Value)	27.17M
Book Value Per Share	0.63
Working Capital	26.96M

Cash Flow

In the last 12 months, operating cash flow was -$25.65 million and capital expenditures -$34,000, giving a free cash flow of -$25.69 million.

Operating Cash Flow	-25.65M
Capital Expenditures	-34,000
Free Cash Flow	-25.69M
FCF Per Share	-$0.50

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DMAC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.37%
Shareholder Yield	-12.37%
Earnings Yield	-8.32%
FCF Yield	-7.22%

Analyst Forecast

The average price target for DMAC is $12.33, which is 79.22% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.33
Price Target Difference	79.22%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 15, 2018. It was a reverse split with a ratio of 1:20.

Last Split Date	Nov 15, 2018
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	1